Although the most effective method remains a topic of debate, GnRH antagonists and progestin‐primed ovarian stimulation (PPOS) protocols are noted for their effectiveness in preventing ovarian hyperstimulation syndrome (OHSS), a potential complication of COS.7 This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.